Friday, June 24, 2016 7:37:39 PM
From CCEL's 8K filed today.
"Stock Purchase Agreement. On June 20, 2016, Cryo-Cell International, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Agreement”) with Ki Yong Choi and Michael Cho (the “Sellers”), collectively the parties (the “Parties”). Pursuant to the Agreement, the Company will purchase 2,179,068 Shares from Ki Yong Choi and 13,416 Shares from Michael Cho (the “Shares”) for $4.50 per share, $9,866,178 in the aggregate (the “Purchase Price”), to be funded through the proceeds of a term loan for approximately $8 million in senior credit facilities and the remainder through the working capital of the Company."
Recent CCEL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 09:29:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 09:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 12:45:07 PM
- Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend • Business Wire • 10/30/2024 12:45:00 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 10/17/2024 09:13:53 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results • Business Wire • 10/15/2024 09:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/15/2024 09:18:02 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/07/2024 09:03:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/07/2024 09:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 09:00:33 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results • Business Wire • 07/15/2024 08:30:00 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results • Business Wire • 04/15/2024 09:00:00 PM
- Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value • Business Wire • 03/25/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 10:20:13 PM
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 • Business Wire • 02/28/2024 10:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:05 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM